William Okkerse

Sr. Director, Global Brand Maximization Teva Pharmaceuticals

William Okkerse is a results-driven leader with a distinguished career in life sciences, specializing in the successful launch and commercialization of specialty care products across various therapeutic areas. With a deep understanding of the end-to-end value chain, he currently leads Global Brand Maximization for innovative medicines at Teva Pharmaceuticals. Prior to this he held various senior leadership roles at Takeda, leading high-performing teams in diverse cultural environments. Including roles as Franchise Head for the Lung Cancer Franchise in the US market, Head of the Rare Disease BU Office in Japan and as member of it's Global Marketing team for GI. Known for his strategic mindset and collaborative leadership style, William has overseen multiple benchmark-beating launches at various organizational levels. His expertise spans launch excellence, cross-functional team leadership, new capability building, change management and customer engagement.

Pharma Launch Excellence Summit Main Conference Day 2: Wednesday 4th December

9:30 AM Morning Panel Discussion: Navigating Geopolitical and Regional Challenges in Launch Excellence

In an increasingly interconnected world, pharmaceutical companies must balance global strategies with local execution to achieve launch success. This session will explore the challenges and opportunities of harmonizing global and local efforts to optimize market impact.

• Aligning global strategies with local market needs to ensure relevance and maximize impact.

• Leveraging local insights to tailor launch tactics and address specific regulatory and market requirements.

• Addressing differences in strategy between regions, countries & overcoming related challenges.

2:00 PM Presentation/Case Study: Evolving Launch Excellence: Building Early Access Capabilities for Global Success

Join this candid discussion exploring the organizational transformation needed to integrate access considerations earlier in development. Drawing from real-world experiences at Teva, discover how pharmaceutical companies are adapting their operating models and capabilities to meet evolving market demands. This session will examine practical approaches to building robust early access strategies while navigating common challenges across diverse markets.

  • Examining different organizational models
  • Exploring critical decision points: When and how to integrate commercial and access perspectives in the development cycle
  • Building effective stage-gate processes: Key deliverables and ownership models that drive better market preparation
  • Managing transformation challenges: Practical insights on evolving ways of working and organizational capabilities

The session will foster open dialogue on shared industry challenges and varied approaches to building launch excellence capabilities, using publicly available examples to spark discussion on different organizational philosophies and solutions.

Check out the incredible speaker line-up to see who will be joining William.

Download The Latest Agenda